What is the Future of Biomarker Assays in Cancer Care?
The future of biomarker assays in cancer care looks promising, with advancements in molecular biology and technology driving the field forward. Emerging areas include liquid biopsies, which allow for the detection of biomarkers in blood samples, providing a less invasive option compared to traditional biopsies. The integration of artificial intelligence and machine learning is also poised to enhance the predictive power of biomarker assays, enabling more accurate and timely decision-making in cancer care.
